Seizure News and Research

Latest Seizure News and Research

FDA warns about risk of Hyland's Teething Tablets to children

The U.S. Food and Drug Administration today is warning consumers that Hyland's Teething Tablets may pose a risk to children. The FDA recommends that consumers not use this product and dispose of any in their possession. The manufacturer is issuing a recall of this product.

25 Oct 2010

UCSF scientists receive grants to refine embryonic stem cell-based strategies for neurological diseases

UCSF scientists have received two grants from the California Institutefor Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure. The goal of the grants is for researchers to make significant strides toward the development of potential therapies within the next three years.

25 Oct 2010

New epilepsy drugs give more options, but make treatment decisions more complex: Epilepsy specialist

A dozen new epilepsy drugs are giving doctors and patients more options, but making treatment decisions more complex, a Loyola epilepsy specialist reports in the journal Neurologic Clinics.

22 Oct 2010

FDA releases redacted copy of warning letter sent to Quality Egg

FDA is releasing a redacted copy of a warning letter sent on October 15, 2010 to Mr. Austin J. DeCoster, owner of Quality Egg LLC of Galt, Iowa. Quality Egg LLC is one of two companies that recalled eggs in August 2010. Quality Egg LLC has not shipped eggs to the table market since the August recalls.

19 Oct 2010

Today's Op-Eds: Critiques of 'Obamacare,' Skyrocketing brand name drug prices, pay-for-performance

People are less negative about some of the specifics than they are about the package as a whole. But does this imply that those who understand the law like it better. Despite their political views, the well-informed share a strong opposition to the new law.

18 Oct 2010

Visa supports global law enforcement action against online sale of counterfeit, illegal medicines

Visa Inc. and Visa Europe today announced support for "Operation Pangea III," a global law enforcement action coordinated by INTERPOL targeting the online sale of counterfeit and illegal medicines resulting in arrests across the globe and the seizure of thousands of potentially harmful medicines.

15 Oct 2010

Study finds TMS is an effective treatment solution for major depression

Transcranial magnetic stimulation (TMS), the treatment delivers a series of electrical pulses to the part of the brain associated with depression and other mood disorders. The pulses generate an electric current in the brain that stimulates neurons to increase the release of more mood-enhancing chemicals like serotonin, dopamine and norepinephrine.

15 Oct 2010

CNF initiates annual event to raise awareness on infantile spasms

The Child Neurology Foundation (CNF) announced today the start of Infantile Spasms Awareness Week, an annual event to raise awareness and understanding of infantile spasms (IS) with pediatricians, child neurologists, parents and caregivers.

14 Oct 2010

Vaccine lawsuits – Justices divided

The US Supreme Court is seemingly divided over the lawsuits on childhood vaccines. The Justices acquiesced that the Congress has done its bit to shield vaccine-makers from suits by the few who have had an adverse reaction to a vaccine approved by the Food and Drug Administration. Now the matter revolves around whether those hurt by vaccines have the right to sue manufacturers if they can prove that a safer version was available.

12 Oct 2010

Attorney Keith Jensen announces $3.78 million settlement with Pfizer on TEN case

Attorney Keith Jensen of the Fort Worth, Texas-based law firm of Jensen, Belew & Gonzalez is announcing a $3.78 million settlement with pharmaceutical manufacturer Pfizer Inc. on behalf of the family of a nine-year-old New York girl who died in June 2004 as the result of a drug-induced disease known as Stevens Johnson Syndrome, which caused all of her skin to peel off.

11 Oct 2010

Abbott to withdraw Meridia medicine from the U.S. market

Abbott will voluntarily withdraw Meridia (sibutramine) from the U.S. market at the request of the U.S. Food and Drug Administration (FDA).

11 Oct 2010

Matchmaker function may help cardiologists understand the natural repair process after heart attacks

Heart muscle cells do not normally replicate in adult tissue, but multiply with abandoned during development. This is why the loss of heart muscle after a heart attack is so dire-you can't grow enough new heart muscle to make up for the loss.

8 Oct 2010

Progress in predicting epileptic seizures

A team of physicists, physicians and neuroscientists at the Bernstein Center of the University Freiburg did a step forward towards the ambitious goal of predicting epileptic seizures, as published in the latest issue of the journal "Epilepsia".

6 Oct 2010

Mass. hospital sale talks seeking to protect employee retirement plans; Conn. Gov. ask for waiver in preexisting insurance plan

Representatives of Caritas Christi Health Care, the private equity firm seeking to buy it, and the attorney general's office are working on a tentative agreement to protect the retirement plans of 13,000 employees and keep the chain's hospitals open for at least five years.

6 Oct 2010

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

New research from Rhode Island Hospital found that reduced levels of brain-derived neurotrophic factor (BDNF), a protein in the brain that encourages growth of neurons, may be a trait marker for individuals with psychogenic non-epileptic seizures (PNES) (seizures that are psychological in origin). The findings are published in the October 4, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

5 Oct 2010

New edition of Sturge-Weber Syndrome textbook published

Eleven years after the first edition, a new edition of the Sturge-Weber Syndrome textbook has been published by the Sturge-Weber Foundation in New Jersey. Co-author E. Steve Roach, MD, is chief of Neurology and vice-chair of Pediatrics at Nationwide Children's Hospital.

4 Oct 2010

Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency

Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS).

1 Oct 2010

FDA issues warning letters to three companies for claiming plaque removal by mouth rinse products

The FDA today issued warning letters to three companies that manufacture and market mouth rinse products with claims that they remove plaque above the gum line or promote healthy gums. These claims suggest the products are effective in preventing gum disease when no such benefit has been demonstrated.

29 Sep 2010

Researchers create device to find ways to improve commonly used treatment for 'water on the brain'

Van Andel Research Institute (VARI) scientists participated in a study with researchers from the University of Utah that could help find ways to improve shunt systems used to treat the neurological disorder hydrocephalus, or "water on the brain," the leading cause of brain surgery for children in the United States. Researchers studied the shunt systems under a variety of conditions by creating a bioreactor that mimics the environment inside patients.

24 Sep 2010

FDA grants clearance for HPβCD treatment for Niemann Pick Type C disease

Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol Cyclo (Hydroxypropyl Beta Cyclodextrin or HPβCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niemann Pick Type C (NPC).

24 Sep 2010

Seizure News and Research

Latest Seizure News and Research

FDA warns about risk of Hyland's Teething Tablets to children

UCSF scientists receive grants to refine embryonic stem cell-based strategies for neurological diseases

New epilepsy drugs give more options, but make treatment decisions more complex: Epilepsy specialist

FDA releases redacted copy of warning letter sent to Quality Egg

Today's Op-Eds: Critiques of 'Obamacare,' Skyrocketing brand name drug prices, pay-for-performance

Visa supports global law enforcement action against online sale of counterfeit, illegal medicines

Study finds TMS is an effective treatment solution for major depression

CNF initiates annual event to raise awareness on infantile spasms

Vaccine lawsuits – Justices divided

Attorney Keith Jensen announces $3.78 million settlement with Pfizer on TEN case

Abbott to withdraw Meridia medicine from the U.S. market

Matchmaker function may help cardiologists understand the natural repair process after heart attacks

Progress in predicting epileptic seizures

Mass. hospital sale talks seeking to protect employee retirement plans; Conn. Gov. ask for waiver in preexisting insurance plan

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

New edition of Sturge-Weber Syndrome textbook published

Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency

FDA issues warning letters to three companies for claiming plaque removal by mouth rinse products

Researchers create device to find ways to improve commonly used treatment for 'water on the brain'

FDA grants clearance for HPβCD treatment for Niemann Pick Type C disease

Everything you need to know about epilepsy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Seizure News and Research

Latest Seizure News and Research

Everything you need to know about epilepsy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in